Volume 42, Issue 6, Pages (June 2005)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in non-small cell lung cancer: Comparison of TB and non-TB endemic regions Chih-Ying.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Volume 59, Issue 1, Pages (July 2013)

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”

Volume 131, Issue 1, Pages (July 2006)

Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.

Volume 42, Issue 6, Pages (June 2005)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Volume 42, Issue 1, Pages (January 2005)

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

The origin of cancer stem cells

Mesenchymal stromal cell therapy for liver diseases

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

The place of downstaging for hepatocellular carcinoma

Volume 68, Issue 3, Pages (March 2018)

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Liver is liver and blood is blood, and finally the twain have met

Genomic risk of hepatitis C-related hepatocellular carcinoma

Autophagy in the liver Journal of Hepatology

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok

HCMV jogs the ‘memory’ of NK cells in HBV

Economics of chronic hepatitis B and hepatitis C

Volume 42, Issue 6, Pages (June 2005)

Volume 50, Issue 4, Pages (April 2009)

Fen Huang, Chenchen Yang, Xinying Zhou, Wenhai Yu, Qiuwei Pan

Paul C. Adams, James C. Barton Journal of Hepatology

Volume 56, Issue 6, Pages (June 2012)

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Global burden of alcoholic liver diseases

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Serum HBV pgRNA as a clinical marker for cccDNA activity

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

Volume 51, Issue 2, Pages (August 2009)

Chronic hepatitis B in children and adolescents

Pathogenesis of cholestatic hepatitis C

Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing Roongruedee Chaiteerakij,

Chimeric mouse model of hepatitis B virus infection

U.P. Neumann, M. Biermer, D. Eurich, P. Neuhaus, T. Berg

Eric Robinet, Thomas F. Baumert Journal of Hepatology

Volume 125, Issue 6, Pages (December 2003)

Presentation transcript:

Volume 42, Issue 6, Pages 813-819 (June 2005) Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area Chee-kin Hui, Jian Sun, Wing-yan Au, Albert K.W. Lie, Yui-hung Yueng, Hai-ying Zhang, Nikki P. Lee, Jin-ling Hou, Raymond Liang, George K.K. Lau Journal of Hepatology Volume 42, Issue 6, Pages 813-819 (June 2005) DOI: 10.1016/j.jhep.2005.01.018 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Comparison of HBV DNA levels among six serum samples determined by real time PCR with the primers for the Core region and the X region. The line passing through the data with a slope equal to one is the hypothetical line that all data points would fall on if the two different sets of primers yielded results in complete agreement with each other. Journal of Hepatology 2005 42, 813-819DOI: (10.1016/j.jhep.2005.01.018) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions